Study S000058

A Comparison of Exenatide and Insulin Glargine on Glycemic Variability in T2DM Patients Inadequately Controlled With Metformin Monotherapy

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

Included trial: extracted data ClinicalTrials.gov record

Registration

Registration: NCT02325960
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: NONE
Status: COMPLETED
Enrollment: 44
Start: 2015-01
Primary completion: 2016-07
Lead sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Conditions: Type 2 Diabetes
Interventions: DRUG:exenatide; DRUG:Insulin glargine
Results posted: FALSE
Individual participant data sharing: UNDECIDED

Registered primary outcomes

Mean amplitude of glycemic excursions (MAGE) change from baseline by continuous glucose monitoring system (CGMS) [1±3day；112±3d]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0024438	Effects of exenatide versus insulin glargine on body composition in overweight and obese T2DM patients: a randomized controlled trial. Yin TT, Nutrition & metabolism	2018	Randomized trial	PMID 30302121 DOI	cites ClinicalTrials.gov:NCT02325960; registry reference DERIVED:30302121